Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.6.3 has replaced the previous Revision: v3.6.2 on the page, indicating a platform update.
    Difference
    0.0%
    Check dated 2026-07-03T14:54:23.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new publication entry is added to Publications detailing a three-year Lebrikizumab extension study with author names; the page revision is updated to v3.6.2, replacing the prior v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-26T12:03:23.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', signaling that the study is closed to new participants, and several help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). Publications references were updated by adding a 2026 Lebrikizumab study citation and removing the older 2025 citation, and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.1%
    Check dated 2026-06-12T00:27:20.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page’s Revision tag changed from v3.5.4 to v3.5.5, indicating a new build of the page. This appears to reflect a behind-the-scenes update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-06-05T00:31:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new version of the page/documentation has been published. This appears to be a minor, behind-the-scenes update rather than a substantive change to the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-21T18:38:14.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Taiwan site listing now specifies Taoyuan City rather than Taoyuan, clarifying the exact location.
    Difference
    0.0%
    Check dated 2026-05-07T09:42:40.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.